The 10th Annual Johns Hopkins Multiple Sclerosis Series
Current and Emerging Treatment Options
This activity is jointly presented by the Johns Hopkins University School of Medicine and the Institute for Johns Hopkins Nursing.
Supported by educational grants from Biogen Idec, Questcor, Genzyme, a Sanofi company, Teva Pharmaceuticals, and EMD Sorono, Inc.
Scroll to the Bottom of this Information to Begin this Course
Release date: May 25, 2015
Valid through: May 25, 2017
Specialty: Neurology, Primary Care
Topic: Multiple Sclerosis
Estimated Time to Complete Activity: 90 minutes
This activity is designed for neurologists, primary care physicians, nurses, and other healthcare providers who treat patients with MS. No prerequisites required.
Multiple sclerosis (MS) has been long considered an inflammatory and demyelinating disease of the central nervous system. In recent years, our increased understanding of MS pathogenesis and the significance of neurodegenerative process has led to the development of more effective therapies. Although there is no cure for MS, current and emerging targeted treatments aim to slow disease progression, reduce relapses, and limit disability. However, many uncertainties remain in the diagnosis, treatment, and overall management of patients with MS: How to recognize symptoms and accurately diagnose MS? Which diagnostic tests should be performed? Which therapies should be used? When to initiate, switch, and/or discontinue treatment? How to optimally manage symptoms while minimizing treatment side effects and improve patient’s health-related quality of life? This interactive web archive captured the presentation and discussion of the latest diagnostic approaches and treatment strategies for optimizing the management of and improving outcomes for patients with MS during the 10th Annual Johns Hopkins Multiple Sclerosis Symposium Series. This presentation reviews current and up-and-coming treatment options for patients with MS.
After participating in this activity, the participant will demonstrate the ability to:
- DISCUSS efficacy and safety data of emerging and currently available therapies.
- APPLY MS diagnosis and management plans in diverse patients.
The Johns Hopkins University School of Medicine and the Institute for Johns Hopkins Nursing take responsibility for the content, quality, and scientific integrity of this CME/CNE activity.
- Physicians — maximum of 1.5 AMA PRA Category 1 Credits™
- Nurses — 1.5 Nursing Contact Hour
All other healthcare professionals completing this course will be issued a statement of participation.
Peter A. Calabresi, MD
Professor of Neurology
Director, Division of Neuroimmunology
Director, The Johns Hopkins Multiple Sclerosis Center
Johns Hopkins Hospital
Kathleen Costello, MS, ANP-BC, MSCN
Associate Vice President, Clinical Care
Advocacy, Services and Research Department
National Multiple Sclerosis Society
Johns Hopkins Neurology
Scott Newsome, DO
Assistant Professor of Neurology
Director, Neurology Outpatient Services
Director, Neurology Infusion Center
Johns Hopkins Neuroimmunology and Neuroinfectious Diseases
Johns Hopkins Hospital
David E. Jones, MD
Chair, MS Section of the American Academy of Neurology
Associate Director, Clinical Operations
James Q. Miller MS Clinic
Assistant Professor of Neurology
University of Virginia Health System
Ellen Mahar Mowry, MD
Assistant Professor of Neurology
Johns Hopkins Multiple Sclerosis Center
Johns Hopkins Hospital
Clyde E. Markowitz, MD
Director, Multiple Sclerosis Center at Penn
Associate Professor of Neurology
Perelman School of Medicine
University of Pennsylvania
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Johns Hopkins University School of Medicine and the Institute for Johns Hopkins Nursing. The Johns Hopkins University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The Institute for Johns Hopkins Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Credit Designation Statements
The Johns Hopkins University School of Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This 1.5 contact hour educational activity is provided by the Institute for Johns Hopkins Nursing. Claim only those contact hours actually spent in the activity.
Full Disclosure Policy Affecting CME Activities
As a provider approved by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of the Johns Hopkins University School of Medicine Office of Continuing Medical Education (OCME) to require signed disclosure of the existence of financial relationships with industry from any individual in a position to control the content of a CME activity sponsored by OCME. Members of the Planning Committee are required to disclose all relationships regardless of their relevance to the content of the activity. Faculty are required to disclose only those relationships that are relevant to their specific presentation. The following relationships have been reported for this activity:
It is the policy of the Institute for Johns Hopkins Nursing to require our continuing nursing education faculty and planning committee members to disclose any financial relationships with companies providing program funding or manufacturers of any commercial products discussed in the educational activity. Detailed disclosures appear below.
Peter A. Calabresi, MD, reports serving as a principal investigator for Biogen Idec, Novartis, and Medimmune; and serving as a consultant for AbbVie Inc, Vaccinex, and Vertex Pharmaceuticals Incorporated.
Scott Newsome, DO, reports serving as a principal investigator and as a consultant for Biogen/Idec and Novartis; and as a consultant for Genzyme Corporation, a Sanofi company.
No other planners have indicated that they have any financial interests or relationships with a commercial entity.
Scott Newsome, DO, reports serving as a principal investigator and as a consultant for Biogen Idec and Novartis; and serving as a consultant for Genzyme Corporation, a Sanofi company.
Clyde E. Markowitz, MD, reports serving as a consultant for Biogen Idec, Bayer, Genzyme Corporation, a Sanofi Company, Genentech, Inc, Novartis, and Teva.
Ellen Mahar Mowry, MD, reports receiving research support from Teva Neuroscience.
No other speakers have indicated that they have any financial interests or relationships with a commercial entity whose products or services are relevant to the content of their presentation(s).
Note: Grants to investigators at The Johns Hopkins University are negotiated and administered by the institution which receives the grants, typically through the Office of Research Administration. Individual investigators who participate in the sponsored project(s) are not directly compensated by the sponsor, but may receive salary or other support from the institution to support their effort on the project(s).
The Institute For Johns Hopkins Nursing Mission Statement
The mission of the Institute for Johns Hopkins Nursing is to share the innovations of Johns Hopkins Nursing in practice, education, and research-locally, nationally, and globally.
Our goal in continuing nursing education is to bring you activities that reflect the expertise and creativity of Johns Hopkins Nursing. Our service values are quality, integrity, flexibility, and personal attentiveness. We appreciate your thoughts and welcome your concerns-please feel free to e-mail us: IJHN@jhmi.edu.
Confidentiality Disclaimer For CME Activity Participants
I certify that I am attending a Johns Hopkins University School of Medicine CME activity for accredited training and/or educational purposes.
I understand that while I am attending in this capacity, I may be exposed to "protected health information," as that term is defined and used in Hopkins policies and in the federal HIPAA privacy regulations (the "Privacy Regulations"). Protected health information is information about a person's health or treatment that identifies the person.
I pledge and agree to use and disclose any of this protected health information only for the training and/or educational purposes of my visit and to keep the information confidential. I agree not to post or discuss this protected health information, including pictures and/or videos, on any social media site (eg, Facebook, Twitter, etc.), in any electronic messaging program or through any portable electronic device.
I understand that I may direct to the Johns Hopkins Privacy Officer any questions I have about my obligations under this Confidentiality Pledge or under any of the Hopkins policies and procedures and applicable laws and regulations related to confidentiality. The contact information is: Johns Hopkins Privacy Officer, telephone: 410-735-6509, e-mail: HIPAA@jhmi.edu.
“The Office of Continuing Medical Education at the Johns Hopkins University School of Medicine, as sponsor of this activity, has relayed information with the CME attendees/participants and certify that the visitor is here for training, education and/or observation purposes only.”
Johns Hopkins University School of Medicine
Office of Continuing Medical Education
720 Rutland Avenue/ Turner 20
Baltimore, Maryland 21205-2195
Reviewed & Approved by: General Counsel, Johns Hopkins Medicine (4/1/09)
Instructions for Participation and Credit
Please complete the preassessment, listen to and view the following archived presentation, and complete the postassessment and evaluation to receive CE credit for this activity. A certificate of participation will be available online immediately following successful completion of the activity.
After reviewing this online activity, participants may receive a certificate by receiving a score of 70% or higher on the CME test and completing an evaluation. A certificate of participation will be available online immediately following successful completion of the activity.
Hardware and Software Requirements
Pentium 800 processor or greater, Windows 98/NT/200/XP* or Mac OS 9/X or later, Microsoft Internet Explorer, Safari, Firefox, Windows Media Player 9.0 or later Flash player, 128 MB of RAM Monitor settings: High color at 800 x 600 pixels, Sound card and speakers, Adobe Acrobat Reader.
You can visit the independent (3rd party) site www.whatismybrowser.com to determine if you have the latest version of your browser.
Disclosure of Unlabeled Use
Off-Label Product Discussion
The following faculty members have disclosed that their presentation will reference unlabeled/unapproved use of drugs or products:
No speaker has indicated that he/she will reference unlabeled/unapproved uses of drugs or products.
Non-Endorsement of Products
The Institute for Johns Hopkins Nursing and the American Nurses Credentialing Center do not endorse the use of any commercial products discussed or displayed in conjunction with this educational activity.
The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of Johns Hopkins University School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings, and adverse effects before administering pharmacologic therapy to patients.
This activity was developed in collaboration with ASiM.